Ipswich Investment Management Co., Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ipswich Investment Management Co., Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,060,322
+4.1%
20,227
+3.2%
0.56%
+7.9%
Q2 2023$1,978,542
+2.4%
19,607
-6.7%
0.52%
-1.3%
Q1 2023$1,932,644
+9.2%
21,007
+7.7%
0.53%
+4.1%
Q4 2022$1,769,675
-10.4%
19,507
-24.9%
0.51%
-19.3%
Q3 2022$1,974,000
-16.7%
25,970
-7.4%
0.63%
-7.9%
Q2 2022$2,370,000
-10.3%
28,038
-6.8%
0.68%
+4.0%
Q1 2022$2,641,000
+6.0%
30,094
+5.6%
0.66%
+12.7%
Q4 2021$2,492,000
+21.3%
28,494
+13.4%
0.58%
+10.6%
Q3 2021$2,054,000
-12.1%
25,119
-2.0%
0.53%
-11.9%
Q2 2021$2,337,000
+6.4%
25,619
-0.3%
0.60%
-3.4%
Q1 2021$2,196,000
-11.5%
25,689
-2.2%
0.62%
-16.9%
Q4 2020$2,480,000
+7.4%
26,265
-1.1%
0.74%
+0.5%
Q3 2020$2,310,000
-0.8%
26,563
-0.4%
0.74%
-7.7%
Q2 2020$2,329,000
+6.0%
26,6630.0%0.80%
-7.2%
Q1 2020$2,198,000
-20.9%
26,663
-9.2%
0.86%
+5.8%
Q4 2019$2,780,000
+8.9%
29,3630.0%0.82%
+0.5%
Q3 2019$2,552,000
-4.8%
29,3630.0%0.81%
-5.0%
Q2 2019$2,681,000
-5.0%
29,3630.0%0.86%
-7.3%
Q1 2019$2,823,000
+11.7%
29,363
-0.3%
0.92%
-0.4%
Q4 2018$2,528,000
+16.5%
29,463
+17.0%
0.93%
+26.3%
Q3 2018$2,170,000
+13.4%
25,185
-0.6%
0.73%
-16.5%
Q2 2018$1,913,000
-0.7%
25,330
+6.3%
0.88%
+8.1%
Q1 2018$1,927,000
+2.5%
23,830
+6.4%
0.81%
+2.1%
Q4 2017$1,880,000
-2.2%
22,3880.0%0.80%
-7.8%
Q3 2017$1,922,000
+2.8%
22,3880.0%0.86%
-1.5%
Q2 2017$1,869,0000.0%22,388
-11.0%
0.88%
+7.6%
Q1 2017$1,869,000
+1.2%
25,163
-0.8%
0.81%
-2.6%
Q4 2016$1,847,000
-6.2%
25,363
+1.7%
0.84%
-13.2%
Q3 2016$1,969,000
-8.4%
24,938
-4.3%
0.96%
-9.5%
Q2 2016$2,150,000
-9.1%
26,058
-17.9%
1.06%
-5.6%
Q1 2016$2,366,000
-52.5%
31,758
-45.1%
1.13%
-49.8%
Q4 2015$4,976,000
-4.7%
57,830
+1.8%
2.24%
-9.7%
Q3 2015$5,221,000
-5.1%
56,805
+1.5%
2.49%
+0.3%
Q2 2015$5,503,000
-12.4%
55,950
-12.2%
2.48%
-10.0%
Q1 2015$6,285,000
+4.0%
63,745
-2.3%
2.75%
+7.0%
Q4 2014$6,045,000
-3.0%
65,245
-1.4%
2.58%
-2.9%
Q3 2014$6,231,000
+2.7%
66,184
-1.2%
2.65%
+12.9%
Q2 2014$6,066,000
+7.4%
67,009
+0.9%
2.35%
-3.3%
Q1 2014$5,648,000
+4.5%
66,434
-1.2%
2.43%
+7.7%
Q4 2013$5,404,000
+5.4%
67,243
+0.6%
2.26%
-2.1%
Q3 2013$5,127,000
+7.8%
66,843
-0.6%
2.31%
+12.4%
Q2 2013$4,758,00067,2742.05%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders